Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Tenet Healthcare Corp のコンセンサス目標株価は $208.09 で、24 人のアナリストの評価に基づいています。最高値は $260(10 29, 2025 に UBS が発表)、最安値は $122(5 1, 2024 に Stephens & Co. が発表)です。直近のアナリスト評価 3 件は Wells Fargo、TD Cowen、Guggenheim により 1 7, 2026、1 7, 2026、12 2, 2025 に発表されました。Wells Fargo、TD Cowen、Guggenheim の平均目標株価は $238.67 で、これらの最新評価から Tenet Healthcare Corp に対して 19.74% のupsideが示唆されています。
1アナリスト評価から算出
| Buy Now | Get Alert | ||||||
|---|---|---|---|---|---|---|---|
| 01/07/2026 | Buy Now | 14.89% | Wells Fargo | $252 → $229 | Maintains | Overweight | Get Alert |
| 01/07/2026 | Buy Now | 15.39% | TD Cowen | $233 → $230 | Maintains | Buy | Get Alert |
| 12/02/2025 | Buy Now | 28.94% | Guggenheim | $238 → $257 | Maintains | Buy | Get Alert |
| 11/21/2025 | Buy Now | 20.41% | Barclays | $229 → $240 | Maintains | Overweight | Get Alert |
| 11/13/2025 | Buy Now | 15.39% | JP Morgan | $200 → $230 | Maintains | Overweight | Get Alert |
| 11/13/2025 | Buy Now | 26.43% | Wells Fargo | $238 → $252 | Maintains | Overweight | Get Alert |
| 11/03/2025 | Buy Now | 20.41% | Truist Securities | $225 → $240 | Reiterates | Buy → Buy | Get Alert |
| 10/30/2025 | Buy Now | 26.43% | RBC Capital | $230 → $252 | Maintains | Outperform | Get Alert |
| 10/29/2025 | Buy Now | 30.44% | UBS | $238 → $260 | Maintains | Buy | Get Alert |
| 10/29/2025 | Buy Now | 22.92% | Cantor Fitzgerald | $190 → $245 | Maintains | Overweight | Get Alert |
| 10/29/2025 | Buy Now | 19.41% | Guggenheim | $221 → $238 | Maintains | Buy | Get Alert |
| 10/17/2025 | Buy Now | 12.88% | Mizuho | $194 → $225 | Maintains | Outperform | Get Alert |
| 10/14/2025 | Buy Now | 12.38% | Goldman Sachs | → $224 | Assumes | → Buy | Get Alert |
| 10/08/2025 | Buy Now | 12.88% | Keybanc | $205 → $225 | Maintains | Overweight | Get Alert |
| 10/07/2025 | Buy Now | 19.41% | Wells Fargo | $200 → $238 | Maintains | Overweight | Get Alert |
| 10/07/2025 | Buy Now | -4.68% | Cantor Fitzgerald | $190 → $190 | Reiterates | Overweight → Overweight | Get Alert |
| 09/18/2025 | Buy Now | 14.89% | Barclays | $208 → $229 | Maintains | Overweight | Get Alert |
| 09/10/2025 | Buy Now | 12.88% | B of A Securities | $205 → $225 | Maintains | Buy | Get Alert |
| 08/26/2025 | Buy Now | -4.68% | Cantor Fitzgerald | $190 → $190 | Reiterates | Overweight → Overweight | Get Alert |
| 08/14/2025 | Buy Now | 0.34% | Wells Fargo | $195 → $200 | Maintains | Overweight | Get Alert |
| 08/04/2025 | Buy Now | 0.34% | JP Morgan | $190 → $200 | Maintains | Overweight | Get Alert |
| 07/28/2025 | Buy Now | — | Wolfe Research | — | Downgrade | Outperform → Peer Perform | Get Alert |
| 07/25/2025 | Buy Now | -16.22% | Baird | $195 → $167 | Maintains | Neutral | Get Alert |
| 07/24/2025 | Buy Now | 4.35% | Barclays | $215 → $208 | Maintains | Overweight | Get Alert |
| 07/23/2025 | Buy Now | 2.85% | B of A Securities | $195 → $205 | Maintains | Buy | Get Alert |
| 07/23/2025 | Buy Now | 19.41% | UBS | $230 → $238 | Maintains | Buy | Get Alert |
| 07/23/2025 | Buy Now | 0.34% | Raymond James | $185 → $200 | Reiterates | Outperform → Outperform | Get Alert |
| 07/23/2025 | Buy Now | -5.68% | Guggenheim | $180 → $188 | Maintains | Buy | Get Alert |
| 07/16/2025 | Buy Now | 2.85% | Truist Securities | $190 → $205 | Maintains | Buy | Get Alert |
| 07/11/2025 | Buy Now | -2.67% | Mizuho | $184 → $194 | Maintains | Outperform | Get Alert |
| 06/09/2025 | Buy Now | 5.36% | Morgan Stanley | $175 → $210 | Maintains | Overweight | Get Alert |
| 06/02/2025 | Buy Now | 7.87% | Barclays | $171 → $215 | Maintains | Overweight | Get Alert |
| 05/29/2025 | Buy Now | -2.17% | Wells Fargo | $150 → $195 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 05/14/2025 | Buy Now | -9.69% | B of A Securities | $165 → $180 | Maintains | Buy | Get Alert |
| 05/12/2025 | Buy Now | -4.68% | Truist Securities | $175 → $190 | Maintains | Buy | Get Alert |
| 05/05/2025 | Buy Now | -22.74% | Goldman Sachs | $134 → $154 | Maintains | Neutral | Get Alert |
| 05/05/2025 | Buy Now | -12.2% | Morgan Stanley | $165 → $175 | Maintains | Overweight | Get Alert |
| 04/30/2025 | Buy Now | -14.21% | Barclays | $161 → $171 | Maintains | Overweight | Get Alert |
| 04/30/2025 | Buy Now | -5.18% | RBC Capital | $183 → $189 | Maintains | Outperform | Get Alert |
| 04/30/2025 | Buy Now | 15.39% | UBS | $217 → $230 | Maintains | Buy | Get Alert |
| 04/15/2025 | Buy Now | -31.27% | Baird | $153 → $137 | Downgrade | Outperform → Neutral | Get Alert |
| 04/09/2025 | Buy Now | -17.22% | Guggenheim | → $165 | Initiates | → Buy | Get Alert |
| 03/26/2025 | Buy Now | -17.22% | Morgan Stanley | → $165 | Initiates | → Overweight | Get Alert |
| 02/13/2025 | Buy Now | -11.2% | Cantor Fitzgerald | $177 → $177 | Reiterates | Overweight → Overweight | Get Alert |
| 02/13/2025 | Buy Now | -19.23% | Barclays | $190 → $161 | Maintains | Overweight | Get Alert |
| 01/07/2025 | Buy Now | -7.18% | Keybanc | $200 → $185 | Maintains | Overweight | Get Alert |
| 01/06/2025 | Buy Now | -12.2% | Truist Securities | $190 → $175 | Maintains | Buy | Get Alert |
| 12/17/2024 | Buy Now | -12.2% | JP Morgan | → $175 | Assumes | → Overweight | Get Alert |
| 12/16/2024 | Buy Now | -29.76% | Goldman Sachs | $196 → $140 | Downgrade | Buy → Neutral | Get Alert |
| 11/25/2024 | Buy Now | -24.74% | Wells Fargo | $205 → $150 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 11/22/2024 | Buy Now | -2.17% | Raymond James | $195 → $195 | Downgrade | Strong Buy → Outperform | Get Alert |
| 11/08/2024 | Buy Now | -4.68% | Barclays | $171 → $190 | Maintains | Overweight | Get Alert |
| 11/06/2024 | Buy Now | 2.85% | Wells Fargo | $195 → $205 | Maintains | Overweight | Get Alert |
| 10/30/2024 | Buy Now | -11.2% | Cantor Fitzgerald | $168 → $177 | Maintains | Overweight | Get Alert |
| 10/30/2024 | Buy Now | -1.67% | Goldman Sachs | $173 → $196 | Maintains | Buy | Get Alert |
| 10/30/2024 | Buy Now | -8.19% | RBC Capital | $174 → $183 | Maintains | Outperform | Get Alert |
| 10/30/2024 | Buy Now | -4.68% | Truist Securities | $180 → $190 | Reiterates | Buy → Buy | Get Alert |
| 10/30/2024 | Buy Now | 8.87% | UBS | $197 → $217 | Maintains | Buy | Get Alert |
| 10/22/2024 | Buy Now | -2.17% | Wells Fargo | $175 → $195 | Maintains | Overweight | Get Alert |
| 10/14/2024 | Buy Now | -9.69% | Truist Securities | $170 → $180 | Maintains | Buy | Get Alert |
| 10/11/2024 | Buy Now | 0.34% | Keybanc | → $200 | Initiates | → Overweight | Get Alert |
| 10/04/2024 | Buy Now | -15.71% | Cantor Fitzgerald | $168 → $168 | Reiterates | Overweight → Overweight | Get Alert |
| 10/01/2024 | Buy Now | -15.71% | Cantor Fitzgerald | $168 → $168 | Reiterates | Overweight → Overweight | Get Alert |
| 08/20/2024 | Buy Now | -15.71% | Cantor Fitzgerald | $168 → $168 | Reiterates | Overweight → Overweight | Get Alert |
| 08/19/2024 | Buy Now | -15.71% | Cantor Fitzgerald | $168 → $168 | Reiterates | Overweight → Overweight | Get Alert |
| 08/14/2024 | Buy Now | -1.16% | UBS | $180 → $197 | Maintains | Buy | Get Alert |
| 07/30/2024 | Buy Now | -13.2% | Goldman Sachs | $156 → $173 | Maintains | Buy | Get Alert |
| 07/30/2024 | Buy Now | -12.2% | Wells Fargo | $145 → $175 | Maintains | Overweight | Get Alert |
| 07/29/2024 | Buy Now | -14.21% | Barclays | $156 → $171 | Maintains | Overweight | Get Alert |
| 07/25/2024 | Buy Now | -14.21% | Citigroup | $139 → $171 | Maintains | Buy | Get Alert |
| 07/25/2024 | Buy Now | -12.2% | Raymond James | $130 → $175 | Maintains | Strong Buy | Get Alert |
| 07/25/2024 | Buy Now | -14.71% | Truist Securities | $155 → $170 | Reiterates | Buy → Buy | Get Alert |
| 07/25/2024 | Buy Now | -15.71% | Cantor Fitzgerald | $112 → $168 | Maintains | Overweight | Get Alert |
| 07/15/2024 | Buy Now | -22.24% | Truist Securities | $130 → $155 | Maintains | Buy | Get Alert |
| 07/10/2024 | Buy Now | -21.73% | Barclays | $147 → $156 | Maintains | Overweight | Get Alert |
| 07/10/2024 | Buy Now | -43.81% | Cantor Fitzgerald | $112 → $112 | Reiterates | Overweight → Overweight | Get Alert |
| 07/09/2024 | Buy Now | -43.81% | Cantor Fitzgerald | $112 → $112 | Reiterates | Overweight → Overweight | Get Alert |
| 07/02/2024 | Buy Now | -43.81% | Cantor Fitzgerald | $112 → $112 | Reiterates | Overweight → Overweight | Get Alert |
| 06/28/2024 | Buy Now | -22.24% | Deutsche Bank | $150 → $155 | Maintains | Buy | Get Alert |
| 05/30/2024 | Buy Now | -29.76% | JP Morgan | $107 → $140 | Maintains | Overweight | Get Alert |
| 05/30/2024 | Buy Now | -24.74% | Deutsche Bank | $126 → $150 | Maintains | Buy | Get Alert |
| 05/30/2024 | Buy Now | -23.24% | Baird | → $153 | Initiates | → Outperform | Get Alert |
| 05/02/2024 | Buy Now | -26.25% | Barclays | $113 → $147 | Maintains | Overweight | Get Alert |
| 05/01/2024 | Buy Now | -38.79% | Stephens & Co. | $95 → $122 | Maintains | Equal-Weight | Get Alert |
| 05/01/2024 | Buy Now | -31.77% | RBC Capital | $109 → $136 | Maintains | Outperform | Get Alert |
| 05/01/2024 | Buy Now | -24.74% | UBS | $137 → $150 | Maintains | Buy | Get Alert |
| 05/01/2024 | Buy Now | -34.78% | Mizuho | $118 → $130 | Reiterates | Buy → Buy | Get Alert |
| 05/01/2024 | Buy Now | -34.78% | Truist Securities | $120 → $130 | Reiterates | Buy → Buy | Get Alert |
| 04/12/2024 | Buy Now | -36.79% | Deutsche Bank | $100 → $126 | Maintains | Buy | Get Alert |
| 04/10/2024 | Buy Now | -47.82% | Cantor Fitzgerald | $104 → $104 | Reiterates | Overweight → Overweight | Get Alert |
| 03/28/2024 | Buy Now | -42.3% | Wells Fargo | $105 → $115 | Maintains | Overweight | Get Alert |
| 03/27/2024 | Buy Now | -38.79% | Wolfe Research | → $122 | Upgrade | Peer Perform → Outperform | Get Alert |
| 03/11/2024 | Buy Now | -44.81% | Mizuho | $100 → $110 | Maintains | Buy | Get Alert |
| 03/06/2024 | Buy Now | -43.31% | Barclays | → $113 | Initiates | → Overweight | Get Alert |
| 03/05/2024 | Buy Now | -47.82% | Cantor Fitzgerald | $104 → $104 | Reiterates | Overweight → Overweight | Get Alert |
| 02/15/2024 | Buy Now | -47.32% | Wells Fargo | $98 → $105 | Maintains | Overweight | Get Alert |
| 02/09/2024 | Buy Now | -47.32% | Truist Securities | $92 → $105 | Maintains | Buy | Get Alert |
| 02/09/2024 | Buy Now | -45.31% | RBC Capital | $97 → $109 | Maintains | Outperform | Get Alert |
| 02/09/2024 | Buy Now | -49.83% | Mizuho | $90 → $100 | Maintains | Buy | Get Alert |
| 02/09/2024 | Buy Now | -47.82% | Cantor Fitzgerald | $94 → $104 | Maintains | Overweight | Get Alert |
Tenet Healthcareの最新目標株価Tenet Healthcare。(NYSE:THC) の最新目標株価をWells Fargoが1 7, 2026日に発表した。このアナリスト会社はTenet Healthcare ({{change}:{{mbol}}) {{{quoteName}}の{{change}:{{symbol}}からriseまで12ヶ月以内(14.89% upsideの可能性あり)と予想する$229.00の目標株価を設定しました。過去1年間に45のアナリスト会社がレーティングを報告しています。
Tenet Healthcareの最新のアナリストレーティングはTenet Healthcareです。(NYSE:THC) の最新のアナリストレーティングはWells Fargoによるもので、Tenet HealthcareのTenet Healthcareです。{actionCompany}}のoverweight評価です。
Tenet Healthcare Corpの最後のアップグレードは5 29, 2025日に行われ、Wells Fargoは目標株価を$195に引き上げました。companyName}}のWells Fargoの以前のan equal-weightは$195でした。
Tenet Healthcare Corpの最後の格下げは7 28, 2025日にWolfe ResearchがTenet Healthcare Corpの目標株価をN/AからN/Aに変更した時です。
アナリストは、公開財務諸表を調べたり、Tenet Healthcareの役員や顧客に話を聞いたり、決算の電話会議を傍聴したりと、広範な調査を行った上で株価の格付けを行っています。ほとんどのアナリストは3ヶ月ごとにこの作業を行いますので、毎年1社につき4つの格付けを得ることになります。companyName}}の最終レーティングは1 7, 2026日に提出されましたので、次のレーティングは1 7, 2027日あたりに提出されるものと思われます。
レーティングは主観的なものであり変化しますが、最新のTenet Healthcare (THC) (THC) のレーティングは維持で、目標株価は$252.00から$229.00でした。現在の価格 Tenet Healthcare ({{exchange}}) (THC) の現在の取引価格は$199.32で、これはアナリストの予測レンジout ofです。
ブラウズ アナリスト評価と目標株価 全銘柄の
